Chronic lung disease following Stevens-Johnson syndrome.
暂无分享,去创建一个
[1] D. Yarbrough. Treatment of toxic epidermal necrolysis in a burn center. , 1997, Journal of the South Carolina Medical Association.
[2] W. Rom,et al. Obliterative bronchiolitis. , 1997, Clinics in chest medicine.
[3] A. Muelenaer,et al. Unusual manifestation of Stevens-Johnson syndrome involving the respiratory and gastrointestinal tract. , 1992, Pediatrics.
[4] N. Nadkarni,et al. Phenytoin induced pseudolymphoma syndrome , 1991 .
[5] E. Scheffer,et al. Drug‐induced pseudolymphomatous skin reactions , 1988, The British journal of dermatology.
[6] G. Shires,et al. Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without Corticosteroids , 1986, Annals of surgery.
[7] Steigleder Gk. Treatment of toxic epidermal necrolysis , 1985 .
[8] G. Redding,et al. Multiple Pulmonary Complications in a Patient with Stevens-Johnson Syndrome , 1984, Clinical pediatrics.
[9] C. Edwards,et al. Mycoplasma pneumonia, Stevens-Johnson syndrome, and chronic obliterative bronchitis. , 1983, Thorax.
[10] C. J. Rosenthal,et al. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation , 1982, Cancer.
[11] M. Arstikaitis. Ocular aftermath of Stevens-Johnson syndrome. , 1973, Archives of ophthalmology.
[12] L. Lasagna,et al. Drugs as etiologic factors in the Stevens-Johnson syndrome. , 1968, The American journal of medicine.